Our earlier calculation that females are at a lower risk of developing TP53 mutations in non-reproductive cancers than males [28] now also appears vitally relevant for female breasts, where the consequences of early p53 malfunction would have devastating consequences for the sustenance of mammalian offspring and, in turn, negatively affect reproductive fecundity. The gene discussed is TP53; the disease is cancer.